» Articles » PMID: 31275852

Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies

Overview
Journal Front Oncol
Specialty Oncology
Date 2019 Jul 6
PMID 31275852
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

(WW domain containing oxidoreductase) expression loss is common in various cancers and characteristic of poor prognosis. Deletions, translocations, and loss of expression affecting the gene are a common feature of various B cell neoplasms such as certain B cell lymphomas and multiple myeloma. However, the role of this common abnormality in B cell tumor initiation and/or progression has not been defined. In this study, we conditionally deleted early in B cell development by means of breeding transgenic mice crossed to floxed mice (). We observed a significant reduced survival in mice and the development of B cell neoplasms including B cell lymphomas, plasma cell neoplasias characterized by increased numbers of CD138+ populations as well as monoclonal gammopathies detected by serum protein electrophoresis. To investigate whether loss could play a role in genomic instability, we analyzed DNA repair functions during immunoglobulin class switch joining between DNA segments in antibody genes. While class switch recombination (CSR) was only slightly impaired, Wwox deficiency resulted in a dramatic shift of double strand break (DSB) repair from normal classical-NHEJ toward the microhomology-mediated alternative-NHEJ pathway, a pathway associated with chromosome translocations and genome instability. Consistent with this, Wwox deficiency resulted in a marked increase of spontaneous translocations during CSR. This work defines for the first time a role for Wwox for maintaining B cell genome stability during a process that can promote neoplastic transformation and monoclonal gammopathies.

Citing Articles

Contemplating the prognostic and therapeutic potential of CD19: a comprehensive analysis across diverse cancer types.

Yang X, Duan Y, Zhao Z Am J Transl Res. 2024; 16(11):6365-6383.

PMID: 39678610 PMC: 11645609. DOI: 10.62347/KJGS9928.


WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.

Hussain T, Sanchez K, Crayton J, Saha D, Jeter C, Lu Y Prog Neurobiol. 2023; 223:102425.

PMID: 36828035 PMC: 10835625. DOI: 10.1016/j.pneurobio.2023.102425.


Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments.

Ha N, Lee C Cells. 2020; 9(11).

PMID: 33113804 PMC: 7693003. DOI: 10.3390/cells9112352.


LncRNA HOTAIRM1 Inhibits the Proliferation and Invasion of Lung Adenocarcinoma Cells via the miR-498/WWOX Axis.

Chen T, Gao F, Yang T, Li H, Li Y, Ren H Cancer Manag Res. 2020; 12:4379-4390.

PMID: 32606933 PMC: 7295110. DOI: 10.2147/CMAR.S244573.

References
1.
Bednarek A, Laflin K, Daniel R, Liao Q, Hawkins K, Aldaz C . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000; 60(8):2140-5. View

2.
Ried K, Finnis M, Hobson L, Mangelsdorf M, Dayan S, Nancarrow J . Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet. 2000; 9(11):1651-63. DOI: 10.1093/hmg/9.11.1651. View

3.
Kuppers R, Dalla-Favera R . Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001; 20(40):5580-94. DOI: 10.1038/sj.onc.1204640. View

4.
Bednarek A, Daniel R, Laflin K, Bergsagel P, Kiguchi K, BRENNER A . WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res. 2001; 61(22):8068-73. View

5.
Krummel K, Denison S, Calhoun E, Phillips L, Smith D . The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer. 2002; 34(2):154-67. DOI: 10.1002/gcc.10047. View